Provided by Tiger Trade Technology Pte. Ltd.

ACADIA Pharmaceuticals

19.78
+0.20001.02%
Post-market: 19.820.0400+0.20%16:00 EDT
Volume:1.47M
Turnover:29.14M
Market Cap:3.41B
PE:9.01
High:20.05
Open:19.60
Low:19.58
Close:19.58
52wk High:30.96
52wk Low:19.32
Shares:172.31M
Float Shares:128.72M
Volume Ratio:0.66
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.20
EPS(LYR):2.30
ROE:35.74%
ROA:3.64%
PB:2.61
PE(LYR):8.60

Loading ...

ACADIA Pharmaceuticals Signals Confident Path After Q1 Call

TIPRANKS
·
May 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evotec AG (EVO), Vaxcyte (PCVX) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 08

RBC Capital Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 07

Analysts Offer Insights on Healthcare Companies: Kissei Pharmaceutical Co (OtherKSPHF), Recursion Pharmaceuticals (RXRX) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 07

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Qiagen (QGEN) and Alcon (ALC)

TIPRANKS
·
May 07

Acadia Pharmaceuticals Q1 revenue rises on DAYBUE growth

Reuters
·
May 07

ACADIA Pharmaceuticals Q1 EPS $0.02 Misses $0.05 Estimate, Sales $268.062M Miss $280.710M Estimate

Benzinga Earnings
·
May 07

BRIEF-Acadia Pharmaceuticals Q1 EPS USD 0.02

Reuters
·
May 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 06

A Look At ACADIA Pharmaceuticals (ACAD) Valuation As Recent Returns Send Mixed Signals

Simply Wall St.
·
May 02

Acadia R&D chief Elizabeth Thompson to retire, company launches successor search

Reuters
·
May 01

ACADIA Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.z. Thompson, Ph.d., Head of Research and Development, Following a Distinguished Career

THOMSON REUTERS
·
May 01

Earning Preview: ACADIA Pharmaceuticals this quarter’s revenue is expected to increase by 17.56%, and institutional views are bullish

Earnings Agent
·
Apr 30

Acadia Pharmaceuticals announces virtual annual shareholder meeting

Reuters
·
Apr 29

ACADIA Pharmaceuticals publishes 2025 annual report

Reuters
·
Apr 29

Analysts Are Bullish on These Healthcare Stocks: Femasys (FEMY), ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
Apr 28

Acadia presents Phase 4 LOTUS real-world DAYBUE data in Rett syndrome at AAN 2026

Reuters
·
Apr 17

Bank of America Securities Remains a Buy on ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
Apr 16

Acadia Pharmaceuticals to report first-quarter results after US market close

Reuters
·
Apr 16

Did DAYBUE STIX’s Flexible Rett Formulation Just Shift ACADIA Pharmaceuticals' (ACAD) Investment Narrative?

Simply Wall St.
·
Apr 16